Published in Circulation on July 01, 1983
Acute hepatitis after parenteral amiodarone administration. Br Heart J (1988) 1.46
Amiodarone pneumonitis: three further cases with a review of published reports. Thorax (1984) 1.04
Amiodarone: the experience of the past decade. Br Med J (Clin Res Ed) (1983) 1.04
Amiodarone pulmonary toxicity: functional and ultrastructural evaluation. Thorax (1986) 0.89
Amiodarone for refractory cardiac arrhythmias: 10-year study. CMAJ (1986) 0.89
Alterations to the electrical activity of atrial muscle isolated from the rat heart, produced by exposure in vitro to amiodarone. Br J Pharmacol (1984) 0.83
Changing arteriosclerotic disease patterns and management strategies in lower-limb-threatening ischemia. Ann Surg (1990) 0.81
Amiodarone in long term prophylaxis. Drugs (1991) 0.79
Iohexol contrast medium induces QT prolongation in amiodarone patients. Br J Clin Pharmacol (2004) 0.75
Adverse reactions during treatment with amiodarone hydrochloride. Br Med J (Clin Res Ed) (1983) 0.75
Amiodarone toxicity: An underdiagnosed entity. Ann Pediatr Cardiol (2016) 0.75
Acute Liver and Renal Failure: A Rare Adverse Effect Exclusive to Intravenous form of Amiodarone. Case Rep Crit Care (2016) 0.75
Ataxia: a diagnostic perplexity and management dilemma. BMJ Case Rep (2013) 0.75
Segmental pulmonary consolidation due to amiodarone. CMAJ (1986) 0.75
Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. Ireland, 6-8 July, 1988. Abstracts. Br J Clin Pharmacol (1988) 0.75
Adverse reactions during treatment with amiodarone hydrochloride. Br Med J (Clin Res Ed) (1983) 0.75
Sudden cardiac death--a perspective. West J Med (1984) 0.75
Recent trends in the management of life-threatening ventricular arrhythmias. West J Med (1984) 0.75
Long term efficacy of class I antiarrhythmic agents and amiodarone in patients with malignant ventricular arrhythmias. Drugs (1985) 0.75
Viral DNA synthesis is required for the efficient expression of specific herpes simplex virus type 1 mRNA species. Virology (1980) 4.05
Characterization of herpes simplex virus type 1 RNA present in the absence of de novo protein synthesis. J Virol (1980) 4.01
Acrasin, Acrasinase, and the sensitivity to acrasin in Dictyostelium discoideum. Dev Biol (1969) 3.56
The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection. J Virol (1988) 3.22
Detailed characterization of the mRNA mapping in the HindIII fragment K region of the herpes simplex virus type 1 genome. J Virol (1981) 3.10
Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol (1983) 3.01
Herpes simplex virus type 1 HindIII fragment L encodes spliced and complementary mRNA species. J Virol (1981) 2.97
Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep (1978) 2.63
'Runner's trots'. Gastrointestinal disturbances in runners. JAMA (1980) 2.46
Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am J Psychiatry (1995) 2.39
An AVID dissent. Pacing Clin Electrophysiol (1994) 2.33
Characterization of a major late herpes simplex virus type 1 mRNA. J Virol (1981) 2.29
Isolation and localization of herpes simplex virus type 1 mRNA. J Virol (1979) 2.23
Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol (1980) 2.17
Isolation and localization of herpes simplex virus type 1 mRNA abundant before viral DNA synthesis. J Virol (1979) 2.16
Interaction of plasma kallikrein with the C1 inhibitor. J Immunol (1970) 2.07
Amiodarone. N Engl J Med (1987) 2.05
Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies. J Clin Invest (1988) 1.94
Advances in the understanding of myocarditis. Circulation (2001) 1.93
A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol (2000) 1.89
Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation (1996) 1.86
A gene encoding an intestinal-enriched member of the Krüppel-like factor family expressed in intestinal epithelial cells. Nucleic Acids Res (1999) 1.85
Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation (1997) 1.84
Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med (1983) 1.81
Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry (1993) 1.81
Arrhythmia discrimination using hemoglobin spectroscopy in humans. Heart Rhythm (2012) 1.68
Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep (1978) 1.68
Techniques for right and left ventricular endomyocardial biopsy. Am J Cardiol (1978) 1.68
A helix-loop-helix transcription factor-like gene is located at the mi locus. J Biol Chem (1993) 1.66
A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosom Med (1969) 1.65
Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis (1990) 1.63
Early anthracycline cardiotoxicity. Am J Med (1978) 1.63
Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry (1993) 1.56
Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups. J Am Coll Cardiol (1990) 1.54
Plasma kallikrein and Hageman factor in Gram-negative bacteremia. Ann Intern Med (1970) 1.53
Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry (1991) 1.52
Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimicrob Agents Chemother (1993) 1.51
Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic Study Versus Electromagnetic Monitoring. Circulation (1997) 1.49
Role of concentration-dependent plasma protein binding in disopyramide disposition. J Pharmacokinet Biopharm (1979) 1.49
Frequency response characteristics of ambulatory ECG monitoring systems and their implications for ST segment analysis. Am Heart J (1982) 1.48
The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states. Ann Intern Med (1969) 1.45
Classification of death in antiarrhythmia trials. J Am Coll Cardiol (1996) 1.44
Multiple hormonal responses to graded exercise in relation to physical training. J Appl Physiol (1972) 1.42
The implantable defibrillator backlash. Am J Cardiol (1991) 1.42
Multicenter study of principles-based waveforms for external defibrillation. Ann Emerg Med (2001) 1.41
Inhibition of insulin secretion by infused epinephrine in rhesus monkeys. Endocrinology (1966) 1.39
Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis (1986) 1.35
Long-term tocainide therapy for ventricular arrhythmias. Circulation (1978) 1.35
Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med (1978) 1.34
Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation (1985) 1.34
Posttranscriptional block to synthesis of a human adenovirus capsid protein in abortively infected monkey cells. J Mol Appl Genet (1983) 1.34
Effects of Physicochemical Factors and Bacterial Colony Morphotype on Association of Vibrio vulnificus with Hemocytes of Crassostrea virginica. Appl Environ Microbiol (1993) 1.32
Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation (1978) 1.28
Malignant ventricular tachyarrhythmias associated with the use of encainide. Am Heart J (1981) 1.27
Atypical atrioventricular node reciprocating tachycardia masquerading as tachycardia using a left-sided accessory pathway. J Am Coll Cardiol (1997) 1.27
Multiple hormonal responses to prolonged exercise in relation to physical training. J Appl Physiol (1972) 1.24
Altered mRNA splicing in monkey cells abortively infected with human adenovirus may be responsible for inefficient synthesis of the virion fiber polypeptide. Proc Natl Acad Sci U S A (1984) 1.24
Viability of Vibrio vulnificus in Association with Hemocytes of the American Oyster (Crassostrea virginica). Appl Environ Microbiol (1995) 1.23
Continuing disability of patients with chest pain and normal coronary arteriograms. J Chronic Dis (1979) 1.21
Ambulatory electrocardiography for diagnosis and treatment of cardiac arrhythmias. N Engl J Med (1976) 1.20
Isolation and translation of mRNA encoded by a specific region of the herpes simplex virus type 1 genome. J Virol (1980) 1.20
Clinical pharmacology of propafenone. Circulation (1983) 1.19
Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol Psychiatry (1993) 1.18
Acebutolol metabolite plasma concentration during chronic oral therapy. Br J Clin Pharmacol (1977) 1.18
3'5' AMP and Ca 2+ in slime mold aggregation. Exp Cell Res (1971) 1.18
Current status of ambulatory electrocardiography. Am Heart J (1981) 1.18
Partial block to transcription of human adenovirus type 2 late genes in abortively infected monkey cells. J Virol (1985) 1.15
Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide. Circulation (1976) 1.15
Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res (1984) 1.14
Endomyocardial biopsy: the balance of success and failure. Circulation (1985) 1.13
Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J Virol (1996) 1.13
Relation between upper limit of vulnerability and defibrillation threshold in humans. Circulation (1993) 1.12
Adenovirus early region 1A modulation of interferon antiviral activity. J Virol (1987) 1.12
Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring Trial. J Am Coll Cardiol (1998) 1.11
Amiodarone pulmonary toxicity and Professor Hounsfield. J Cardiovasc Electrophysiol (2001) 1.10
Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treat Rep (1978) 1.10
Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation. Am J Surg Pathol (1977) 1.10
Differential electrophysiologic properties of decremental retrograde pathways in long RP' tachycardia. Circulation (1987) 1.08
Synthesis of human adenovirus early RNA species is similar in productive and abortive infections of monkey and human cells. J Virol (1982) 1.08
A re-evaluation of the concept of "non-specificity" in stress theory. J Psychiatr Res (1971) 1.08
Endomyocardial biopsy. Ann Intern Med (1982) 1.07
Enhancing the precision of ECG baseline correction: selective filtering and removal of residual error. Comput Biomed Res (2000) 1.07
Why the antiarrhythmics versus implantable defibrillator (AVID) trial sets the wrong precedent. Am J Cardiol (1997) 1.07
Arrhythmias in patients with mitral valve prolapse. Circulation (1975) 1.06
Surgical management of life-threatening ventricular arrhythmias in patients with coronary artery disease. Circulation (1977) 1.05
Prolongation of the human cardiac monophasic action potential by sotalol. Am J Cardiol (1982) 1.05
Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review. Am J Cardiol (1982) 1.05
Efficacy and cost of cardiac monitoring in patients receiving doxorubicin. Cancer (1982) 1.04
Autonomic nervous system and arrhythmias: studies in the transplanted denervated human heart. Cardiology (1976) 1.04
Amiodarone blocks inactivated cardiac sodium channels. Pflugers Arch (1983) 1.04
Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Am Heart J (1981) 1.04
Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol (1987) 1.03